Free Trial
NASDAQ:BPTH

Bio-Path (BPTH) Stock Price, News & Analysis

Bio-Path logo
$0.12 +0.02 (+23.27%)
As of 08/28/2025 03:58 PM Eastern

About Bio-Path Stock (NASDAQ:BPTH)

Key Stats

Today's Range
$0.10
$0.12
50-Day Range
$0.10
$0.19
52-Week Range
$0.09
$3.39
Volume
54,711 shs
Average Volume
178,768 shs
Market Capitalization
$1.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bio-Path Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

BPTH MarketRank™: 

Bio-Path scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bio-Path.

  • Earnings Growth

    Earnings for Bio-Path are expected to grow in the coming year, from ($3.34) to ($1.55) per share.

  • Price to Book Value per Share Ratio

    Bio-Path has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bio-Path's valuation and earnings.
  • Percentage of Shares Shorted

    0.13% of the float of Bio-Path has been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently decreased by 76.45%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bio-Path does not currently pay a dividend.

  • Dividend Growth

    Bio-Path does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.13% of the float of Bio-Path has been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently decreased by 76.45%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    2 people have added Bio-Path to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bio-Path insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.72% of the stock of Bio-Path is held by insiders.

  • Percentage Held by Institutions

    Only 5.74% of the stock of Bio-Path is held by institutions.

  • Read more about Bio-Path's insider trading history.
Receive BPTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BPTH Stock News Headlines

Bio-Path: Q2 Earnings Snapshot
Bio-Path Holdings, Inc. (BPTH) - Yahoo Finance
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
See More Headlines

BPTH Stock Analysis - Frequently Asked Questions

Bio-Path's stock was trading at $1.16 at the beginning of the year. Since then, BPTH shares have decreased by 89.3% and is now trading at $0.1245.

Bio-Path Holdings, Inc. (NASDAQ:BPTH) announced its earnings results on Thursday, August, 15th. The company reported ($1.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.54) by $0.38.
Read the conference call transcript
.

Bio-Path shares reverse split on Friday, February 23rd 2024.The 1-20 reverse split was announced on Friday, February 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of BPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bio-Path investors own include NVIDIA (NVDA), Canopy Growth (CGC), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU), Anavex Life Sciences (AVXL) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
8/15/2024
Today
8/29/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BPTH
CIK
1133818
Fax
N/A
Employees
10
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-2,842.40%
Return on Assets
-337.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
0.86

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
0.18

Miscellaneous

Outstanding Shares
8,308,000
Free Float
5,726,000
Market Cap
$1.03 million
Optionable
Optionable
Beta
-0.06

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:BPTH) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners